RESUMO
Critically ill patients are at heightened risk for nosocomial infections. The anaphylatoxin C5a impairs phagocytosis by neutrophils. However, the mechanisms by which this occurs and the relevance for acquisition of nosocomial infection remain undetermined. We aimed to characterize mechanisms by which C5a inhibits phagocytosis in vitro and in critically ill patients, and to define the relationship between C5a-mediated dysfunction and acquisition of nosocomial infection. In healthy human neutrophils, C5a significantly inhibited RhoA activation, preventing actin polymerization and phagocytosis. RhoA inhibition was mediated by PI3Kδ. The effects on RhoA, actin, and phagocytosis were fully reversed by GM-CSF. Parallel observations were made in neutrophils from critically ill patients, that is, impaired phagocytosis was associated with inhibition of RhoA and actin polymerization, and reversed by GM-CSF. Among a cohort of 60 critically ill patients, C5a-mediated neutrophil dysfunction (as determined by reduced CD88 expression) was a strong predictor for subsequent acquisition of nosocomial infection (relative risk, 5.8; 95% confidence interval, 1.5-22; P = .0007), and remained independent of time effects as assessed by survival analysis (hazard ratio, 5.0; 95% confidence interval, 1.3-8.3; P = .01). In conclusion, this study provides new insight into the mechanisms underlying immunocompromise in critical illness and suggests novel avenues for therapy and prevention of nosocomial infection.
Assuntos
Complemento C5a/imunologia , Estado Terminal , Infecção Hospitalar/imunologia , Neutrófilos/imunologia , Fagocitose/imunologia , Actinas/imunologia , Actinas/metabolismo , Separação Celular , Infecção Hospitalar/epidemiologia , Citometria de Fluxo , Humanos , Polimerização , Proteína rhoA de Ligação ao GTP/imunologia , Proteína rhoA de Ligação ao GTP/metabolismoRESUMO
The magnocellular neurons of the hypothalamic supraoptic nucleus (SON) are a major source of both systemic and central release of the neurohypophyseal peptides, oxytocin (OXT) and arginine-vasopressin (AVP). Both OXT and AVP are released from the somatodendritic compartment of magnocellular neurons and act within the SON to modulate the electrophysiological function of these cells. Cannabinoids (CBs) affect hormonal output and the SON may represent a neural substrate through which CBs exert specific physiological and behavioural effects. Dynamic modulation of synaptic inputs is a fundamental mechanism through which neuronal output is controlled. Dendritically released OXT acts on autoreceptors to generate endocannabinoids (eCBs) which modify both excitatory and inhibitory inputs to OXT neurons through actions on presynaptic CB receptors. As such, OXT and eCBs cooperate to shape the electrophysiological properties of magnocellular OXT neurons, regulating the physiological function of this nucleus. Further study of eCB signalling in the SON, including its interaction with AVP neurons, promises to extend our understanding of the synaptic regulation of SON physiological function.
Assuntos
Encéfalo/fisiologia , Moduladores de Receptores de Canabinoides/fisiologia , Neuro-Hipófise/fisiologia , Núcleo Supraóptico/fisiologia , Transmissão Sináptica/fisiologia , Animais , Arginina Vasopressina/metabolismo , Líquidos Corporais/fisiologia , Células Dendríticas/metabolismo , Homeostase/fisiologia , Camundongos , Neurônios/metabolismo , Ocitocina/metabolismo , Receptores de Ocitocina/fisiologia , Sistemas do Segundo Mensageiro/fisiologia , Sinapses/fisiologiaRESUMO
N-terminally tagged CB1 receptor fusion proteins, incorporating enhanced green fluorescent protein (GFP) or super-ecliptic pHluorin (SEP), were generated to study CB1 receptor trafficking and cell surface receptor expression in live COS7 and HEK293 cells and hippocampal neurons. An artificial signal sequence (SS) was required for efficient surface expression of CB1 receptor chimeras, which behaved like wild-type CB1 receptors in functional assays. Treatment with cannabinoid ligands led to a rapid down-regulation of SS-GFP-CB1 from the plasma membrane in COS7 and HEK293 cells, associated with trafficking into cytosolic vesicles. Activation of CB1 receptors was also linked with a time-dependent reduction in cell surface SEP-CB1 fluorescence and incorporation of the construct into acidic endosomes, revealed following exposure to NH4Cl. In live hippocampal neurons, SEP-CB1 fluorescence was largely restricted to the axon, consistent with its polarised surface expression. Thus, these new molecular tools are well suited for studying CB1 receptor trafficking and a new generation of GPCR chimeras incorporating SEP at the N-terminus will be especially useful for monitoring dynamic changes in cell surface receptor expression in living cells.
Assuntos
Proteínas Luminescentes/metabolismo , Proteínas Mutantes Quiméricas/metabolismo , Neurônios/fisiologia , Receptor CB1 de Canabinoide/metabolismo , Animais , Animais Recém-Nascidos , Células Cultivadas , Chlorocebus aethiops , Cricetinae , AMP Cíclico/metabolismo , Diagnóstico por Imagem/métodos , Endocitose/efeitos dos fármacos , Endocitose/fisiologia , Ensaio de Imunoadsorção Enzimática/métodos , Hipocampo/citologia , Mutagênese/fisiologia , Ratos , Receptor CB1 de Canabinoide/química , Transfecção/métodosRESUMO
In central neurons, the cell-surface distribution of cannabinoid receptor subtype-1 (CB(1)) is highly polarized toward axons and is associated with synaptic terminals, in which it is well-positioned to modulate neurotransmitter release. It has been suggested that high levels of constitutive activity mediate CB(1) receptor axonal targeting, leading to domain-specific endocytosis. We have investigated further the mechanisms that underlie CB(1) receptor axonal polarization in hippocampal neurons and found that constitutive activity is not an essential requirement for this process. We demonstrate that the cell-surface distribution of an N-terminally tagged, fluorescent CB(1) receptor fusion-protein is almost exclusively localized to the axon when expressed in cultured hippocampal neurons. Inhibition of endocytosis by cotransfection with a dominant-negative dynamin-1 (K44A) mutant traps both recombinant and endogenous CB(1) receptors at the somatodendritic cell surface. However, this effect could not be mimicked by inhibiting constitutive activity or receptor activation, either by expressing mutant receptors that lack these properties or by treatment with CB(1) receptor antagonists possessing inverse agonist activity. These data are consistent with a revised model in which domain-specific endocytosis regulates the functional polarization of CB(1) receptors, but this process is distinct from constitutive activity.
Assuntos
Axônios/química , Endocitose/fisiologia , Hipocampo/citologia , Receptor CB1 de Canabinoide/análise , Animais , Células Cultivadas , Neuritos/química , Neurônios/química , Neurônios/citologia , Neurônios/ultraestrutura , Transporte Proteico , Ratos , Receptor CB1 de Canabinoide/metabolismoRESUMO
RIC-3 has been identified as a molecule essential for the recruitment of functional nicotinic acetylcholine receptors composed of alpha7, but it exhibits inhibitory effects on alpha4beta2 or alpha3beta4 receptors. In this study, we investigated the role of RIC-3 in the recruitment of 5-hydroxytryptamine type 3A (5-HT(3A)) receptors to the cell surface. Although RIC-3 is not essential for the surface transport of 5-HT(3A) receptors, we found that its presence enhances both receptor transport and function in a concentration-dependent manner. RIC-3 is localized to the endoplasmic reticulum, as evidenced by co-localization with the chaperone molecule, binding protein (BiP). RIC-3 is not detected at significant levels on the cell surface when expressed alone or in the presence of 5-HT(3A). RIC-3 and 5-HT(3A) show a low level interaction that is transient (<4 h). That RIC-3 can interact with an endoplasmic reticulum-retained 5-HT(3A) construct, combined with the transient interaction observed and lack of significant surface-expressed RIC-3, suggests that RIC-3 may play a role in 5-HT(3A) receptor folding, assembly, or transport to the cell surface.
Assuntos
Membrana Celular/metabolismo , Proteínas/metabolismo , Receptores 5-HT3 de Serotonina/biossíntese , Animais , Biotinilação , Células COS , Linhagem Celular , DNA Complementar/metabolismo , Relação Dose-Resposta a Droga , Retículo Endoplasmático/metabolismo , Ensaio de Imunoadsorção Enzimática , Humanos , Imuno-Histoquímica , Imunoprecipitação , Peptídeos e Proteínas de Sinalização Intracelular , Potenciais da Membrana , Microscopia de Fluorescência , Ligação Proteica , Dobramento de Proteína , Transporte Proteico , Fatores de TempoRESUMO
Given the association of a gamma2 mutation (R43Q) with epilepsy and the reduced cell surface expression of mutant receptors, we investigated a role for this residue in alpha1beta2gamma2 receptor assembly when present in each subunit. Regardless of which subunit contained the mutation, mutant GABA(A) receptors assembled poorly into functional cell surface receptors. The low level of functional expression gives rise to reduced GABA EC50s (alpha1(R43Q)beta2gamma2 and alpha1beta2(R43Q)gamma2) or reduced benzodiazepine potentiation of GABA-evoked currents (alpha1beta2gamma2(R43Q)). We determined that a 15-residue peptide surrounding R43 is capable of subunit binding, with a profile that reflected the orientation of subunits in the pentameric receptor. Subunit binding is perturbed when the R43Q mutation is present suggesting that this residue is critical for the formation of inter-subunit contacts at (+) interfaces of GABAA subunits. Rather than being excluded from receptors, gamma2(R43Q) may form non-productive subunit interactions leading to a dominant negative effect on other receptor subtypes.